Literature DB >> 16176726

Fetal growth restriction and schizophrenia: a Swedish twin study.

Emma Nilsson1, Gabriella Stålberg, Paul Lichtenstein, Sven Cnattingius, Petra Otterblad Olausson, Christina M Hultman.   

Abstract

Obstetric complications increase the risk of schizophrenia. However, it is not known whether there is a causal relation or whether the association is mediated by genetic and/or shared environmental effects. The aim of this study was to investigate the associations between birthweight, other birth characteristics, and schizophrenia. Twin pairs discordant for schizophrenia will also control for unmeasured genetic and shared environmental effects. Prospectively filed obstetric records were used for a cohort analysis of 11,360 same-sexed twins, and within-twin pair analyses were conducted on 90 twin pairs discordant for schizophrenia. The results from the cohort study showed that low birthweight (less than or equal to 1999 grams; odds ratio [OR] 1.67, 95% confidence interval [CI] 0.88-3.14 and 2000-2299 grams; OR 1.79, 95% CI 1.07-3.01) and small head circumference (less than or equal to 31.5 cm; OR 1.61, 95% CI 1.03-2.51) were associated with later development of schizophrenia. The associations remained in the within-pair analyses. The association between low birthweight and schizophrenia is partly a function of reduced fetal growth. Fetal growth restriction seems to be associated with risk of schizophrenia independently of familial factors.

Entities:  

Mesh:

Year:  2005        PMID: 16176726     DOI: 10.1375/1832427054936727

Source DB:  PubMed          Journal:  Twin Res Hum Genet        ISSN: 1832-4274            Impact factor:   1.587


  14 in total

Review 1.  The role of obstetric events in schizophrenia.

Authors:  Mary Catherine Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2005-11-23       Impact factor: 9.306

Review 2.  Early developmental conditioning of later health and disease: physiology or pathophysiology?

Authors:  M A Hanson; P D Gluckman
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

3.  Perinatal risk factors in offenders with severe personality disorder: a population-based investigation.

Authors:  Seena Fazel; Liliya Bakiyeva; Sven Cnattingius; Martin Grann; Christina M Hultman; Paul Lichtenstein; John R Geddes
Journal:  J Pers Disord       Date:  2012-10

Review 4.  The aetiology of schizophrenia: what have the Swedish Medical Registers taught us?

Authors:  Sarah Harper; Helen Towers-Evans; James MacCabe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-06-19       Impact factor: 4.328

5.  Association of Fetal Growth With General and Specific Mental Health Conditions.

Authors:  Erik Pettersson; Henrik Larsson; Brian D'Onofrio; Catarina Almqvist; Paul Lichtenstein
Journal:  JAMA Psychiatry       Date:  2019-05-01       Impact factor: 21.596

6.  Modeling the variability of shapes of a human placenta.

Authors:  M Yampolsky; C M Salafia; O Shlakhter; D Haas; B Eucker; J Thorp
Journal:  Placenta       Date:  2008-07-31       Impact factor: 3.481

7.  Association between prepartum maternal iron deficiency and offspring risk of schizophrenia: population-based cohort study with linkage of Danish national registers.

Authors:  Holger J Sørensen; Philip R Nielsen; Carsten B Pedersen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2010-01-21       Impact factor: 9.306

8.  Non-linear and gender-specific relationships among placental growth measures and the fetoplacental weight ratio.

Authors:  D P Misra; C M Salafia; R K Miller; A K Charles
Journal:  Placenta       Date:  2009-10-29       Impact factor: 3.481

9.  Genomic sister-disorders of neurodevelopment: an evolutionary approach.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Evol Appl       Date:  2009-01-07       Impact factor: 5.183

Review 10.  Low birth weight in the offspring of women with anorexia nervosa.

Authors:  Francesca Solmi; Hannah Sallis; Daniel Stahl; Janet Treasure; Nadia Micali
Journal:  Epidemiol Rev       Date:  2013-09-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.